Shimon Edvardson1, Frank Gerhard2, Chaim Jalas3, Jens Lachmann2, Dafna Golan4, Ann Saada1, Avraham Shaag1, Christian Ungermann2, Orly Elpeleg1. 1. Monique and Jacques Roboh Department of Genetic Research, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. 2. Department of Biology/Chemistry, Biochemistry Section, University of Osnabrück, Osnabrück, Germany. 3. Bonei Olam, Center for Rare Jewish Genetic Disorders, Brooklyn, New York, USA. 4. Maccabi Health Services, Child Development Center, Jerusalem, Israel.
Abstract
BACKGROUND: The genetic heterogeneity of developmental delay and cognitive impairment is vast. The endocytic network is essential for neural development and synaptic plasticity by regulating the sorting of numerous transmembrane proteins. Disruption of the pathway can lead to neuronal pathology. Endosomal biogenesis relies on two Rab proteins, Rab5 and Rab7, which bind to two hexameric tethering complexes, the endosomal class C core vacuole/endosome tethering complex (CORVET) and the late endosomal/lysosomal homotypic fusion and protein sorting complex (HOPS). Both complexes consist of four core proteins and differ by their specific Rab-binding proteins. OBJECTIVES: To identify the molecular basis of a neurological disease, which consists of global developmental stagnation at 3-8 months, increasing appendicular spasticity, truncal hypotonia and acquired microcephaly, with variable seizure disorder, accompanied by thin corpus callosum, paucity of white matter and delayed myelination in eight patients from four unrelated Ashkenazi-Jewish (AJ) families. METHODS: Exome analysis, homozygosity mapping and Mup1-GFP transport assay in mutant yeast. RESULTS: Homozygosity for a missense mutation, p.Cys846Gly, in one of the endosomal biogenesis core proteins, VPS11, was identified in all the patients. This was shown to be a founder mutation with a carrier frequency of 0.6% in the AJ population. The homologous yeast mutant had moderate impairment of fusion of the late endosome to the vacuole in Mup1-GFP transport assay. CONCLUSIONS: We speculate that in neuronal cells, impairment of fusion of the late endosome to the vacuole would attenuate the degradation of plasma membrane receptors, thereby underlying the progressive neuronal phenotype in our patients. The VPS11 p.Cys846Gly mutation should be added to the AJ carrier screening panel. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
BACKGROUND: The genetic heterogeneity of developmental delay and cognitive impairment is vast. The endocytic network is essential for neural development and synaptic plasticity by regulating the sorting of numerous transmembrane proteins. Disruption of the pathway can lead to neuronal pathology. Endosomal biogenesis relies on two Rab proteins, Rab5 and Rab7, which bind to two hexameric tethering complexes, the endosomal class C core vacuole/endosome tethering complex (CORVET) and the late endosomal/lysosomal homotypic fusion and protein sorting complex (HOPS). Both complexes consist of four core proteins and differ by their specific Rab-binding proteins. OBJECTIVES: To identify the molecular basis of a neurological disease, which consists of global developmental stagnation at 3-8 months, increasing appendicular spasticity, truncal hypotonia and acquired microcephaly, with variable seizure disorder, accompanied by thin corpus callosum, paucity of white matter and delayed myelination in eight patients from four unrelated Ashkenazi-Jewish (AJ) families. METHODS: Exome analysis, homozygosity mapping and Mup1-GFP transport assay in mutant yeast. RESULTS: Homozygosity for a missense mutation, p.Cys846Gly, in one of the endosomal biogenesis core proteins, VPS11, was identified in all the patients. This was shown to be a founder mutation with a carrier frequency of 0.6% in the AJ population. The homologous yeast mutant had moderate impairment of fusion of the late endosome to the vacuole in Mup1-GFP transport assay. CONCLUSIONS: We speculate that in neuronal cells, impairment of fusion of the late endosome to the vacuole would attenuate the degradation of plasma membrane receptors, thereby underlying the progressive neuronal phenotype in our patients. The VPS11p.Cys846Gly mutation should be added to the AJ carrier screening panel. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Authors: Cas Simons; David Dyment; Stephen J Bent; Joanna Crawford; Marc D'Hooghe; Alfried Kohlschütter; Sunita Venkateswaran; Guy Helman; Bwee-Tien Poll-The; Christine C Makowski; Yoko Ito; Kristin Kernohan; Taila Hartley; Quinten Waisfisz; Ryan J Taft; Marjo S van der Knaap; Nicole I Wolf Journal: Brain Date: 2017-12-01 Impact factor: 13.501
Authors: Guido Vogt; Sarah Verheyen; Sarina Schwartzmann; Nadja Ehmke; Cornelia Potratz; Anette Schwerin-Nagel; Barbara Plecko; Manuel Holtgrewe; Dominik Seelow; Jasmin Blatterer; Michael R Speicher; Uwe Kornak; Denise Horn; Stefan Mundlos; Björn Fischer-Zirnsak; Felix Boschann Journal: J Med Genet Date: 2021-06-18 Impact factor: 5.941
Authors: Kalliopi Sofou; Kolja Meier; Leslie E Sanderson; Debora Kaminski; Laia Montoliu-Gaya; Emma Samuelsson; Maria Blomqvist; Lotta Agholme; Jutta Gärtner; Chris Mühlhausen; Niklas Darin; Tahsin Stefan Barakat; Lars Schlotawa; Tjakko van Ham; Jorge Asin Cayuela; Fredrik H Sterky Journal: EMBO Mol Med Date: 2021-05-03 Impact factor: 14.260
Authors: Reini E N van der Welle; Rebekah Jobling; Christian Burns; Paolo Sanza; Jan A van der Beek; Alfonso Fasano; Lan Chen; Fried J Zwartkruis; Susan Zwakenberg; Edward F Griffin; Corlinda Ten Brink; Tineke Veenendaal; Nalan Liv; Conny M A van Ravenswaaij-Arts; Henny H Lemmink; Rolph Pfundt; Susan Blaser; Carolina Sepulveda; Andres M Lozano; Grace Yoon; Teresa Santiago-Sim; Cedric S Asensio; Guy A Caldwell; Kim A Caldwell; David Chitayat; Judith Klumperman Journal: EMBO Mol Med Date: 2021-04-14 Impact factor: 12.137
Authors: Manuel A Rivas; Brandon E Avila; Jukka Koskela; Hailiang Huang; Christine Stevens; Matti Pirinen; Talin Haritunians; Benjamin M Neale; Mitja Kurki; Andrea Ganna; Daniel Graham; Benjamin Glaser; Inga Peter; Gil Atzmon; Nir Barzilai; Adam P Levine; Elena Schiff; Nikolas Pontikos; Ben Weisburd; Monkol Lek; Konrad J Karczewski; Jonathan Bloom; Eric V Minikel; Britt-Sabina Petersen; Laurent Beaugerie; Philippe Seksik; Jacques Cosnes; Stefan Schreiber; Bernd Bokemeyer; Johannes Bethge; Graham Heap; Tariq Ahmad; Vincent Plagnol; Anthony W Segal; Stephan Targan; Dan Turner; Paivi Saavalainen; Martti Farkkila; Kimmo Kontula; Aarno Palotie; Steven R Brant; Richard H Duerr; Mark S Silverberg; John D Rioux; Rinse K Weersma; Andre Franke; Luke Jostins; Carl A Anderson; Jeffrey C Barrett; Daniel G MacArthur; Chaim Jalas; Harry Sokol; Ramnik J Xavier; Ann Pulver; Judy H Cho; Dermot P B McGovern; Mark J Daly Journal: PLoS Genet Date: 2018-05-24 Impact factor: 5.917
Authors: Christine A Rygiel; Dana C Dolinoy; Kelly M Bakulski; Max T Aung; Wei Perng; Tamara R Jones; Maritsa Solano-González; Howard Hu; Martha M Tellez-Rojo; Lourdes Schnaas; Erika Marcela; Karen E Peterson; Jaclyn M Goodrich Journal: Environ Epigenet Date: 2021-06-16